Presence of a potent transcription activating sequence in the p53 protein.

The p53 gene is frequently mutated in a wide variety of human cancers. However, the role of the wild-type p53 gene in growth control is not known. Hybrid proteins that contain the DNA binding domain of yeast GAL4 and portions of p53 have been used to show that the p53 protein contains a transcription-activating sequence that functions in both yeast and mammalian cells. The NH2-terminal 73 residues of p53 activated transcription in mammalian cells as efficiently as the herpes virus protein VP16, which contains one of the strongest known activation domains. Combined with previous data that showed p53 is localized to the nucleus and can bind to DNA, these results support the idea that one function of p53 is to activate the transcription of genes that suppress cell proliferation.

[1]  D. Lane,et al.  T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.

[2]  P. Goodfellow,et al.  Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. Khoury,et al.  p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Levine,et al.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.

[5]  D. Lane,et al.  Cellular proteins involved in SV40 transformation , 1983 .

[6]  V. Rotter,et al.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation , 1984, Nature.

[7]  J. Jenkins,et al.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53 , 1984, Nature.

[8]  P. Gruss,et al.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells , 1984, Nature.

[9]  C. Yanisch-Perron,et al.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. , 1985, Gene.

[10]  K. Struhl,et al.  Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of Yeast , 1986, Cell.

[11]  M. Ptashne,et al.  Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein. , 1986, Science.

[12]  M. Horowitz,et al.  The long terminal repeat of the intracisternal A particle as a target for transactivation by oncogene products , 1986, Journal of virology.

[13]  R. Carroll,et al.  Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Levine,et al.  Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex , 1986, Journal of virology.

[15]  E. Moran,et al.  Multiple functional domains in the adenovirus E1A gene , 1987, Cell.

[16]  Mark Ptashne,et al.  Mutants of GAL4 protein altered in an activation function , 1987, Cell.

[17]  Jun Ma,et al.  Deletion analysis of GAL4 defines two transcriptional activating segments , 1987, Cell.

[18]  Jun Ma,et al.  A new class of yeast transcriptional activators , 1987, Cell.

[19]  Mark Ptashne,et al.  Negative effect of the transcriptional activator GAL4 , 1988, Nature.

[20]  Jun Ma,et al.  GAL4-VP16 is an unusually potent transcriptional activator , 1988, Nature.

[21]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[22]  A. Levine,et al.  The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.

[23]  Michael R. Green,et al.  Transcription activation by the adenovirus E1a protein , 1989, Nature.

[24]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[25]  M. Oren,et al.  Wild-type p53 can inhibit oncogene-mediated focus formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.